Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-050224

Chief Financial Officer sold 10,000 shares at $40.00 ($400,000)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-10 Exercise or conversion : show line 1 in the form +1,412 $6.32 $8,924 2,412 D
2020-09-10 Sale : show line 2 in the form −1,412 $40.00 $56,480 1,000 D
2020-09-11 Exercise or conversion : show line 3 in the form +8,588 $6.32 $54,276 9,588 D
2020-09-11 Sale : show line 4 in the form −8,588 $40.00 $343,520 1,000 D
Open-market sales · 10,000 sh · avg $40.00 · $400,000

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-09-10 Exercise or conversion : show line 5 in the form Stock Option (Right To Buy) −1,412 588,588 D
2020-09-11 Exercise or conversion : show line 6 in the form Stock Option (Right To Buy) −8,588 580,000 D
Loading xslF345X03/doc4.xml…